Moneycontrol PRO
HomeNewsBusinessStocksBuy State Bank of India; target of Rs 390: ICICI Direct

Buy State Bank of India; target of Rs 390: ICICI Direct

ICICI Direct is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 390 in its research report dated November 23, 2017.

November 28, 2017 / 17:22 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    ICICI Direct's research report on State Bank of India

    After a soft Q1FY18 (first quarter when merged financials were announced) in terms of asset quality, SBI reported an improved Q2FY18 performance with slippages lower at Rs 10627 crore vs. Rs 30059 in Q1FY18. Corporate slippages were at Rs 4538 crore (54% from watch list). As per the management, going ahead, corporate slippages would largely occur from watch list. The watch list fell 13% QoQ and is now at Rs 21288 crore. Stressed assets (GNPA + RA) were at Rs 220139 crore (11.6% of loans) vs. Rs 227406 crore (12.05% of loans) in Q1FY18. Including accounts under SDR & S4A, overall stressed assets are below 14%, better than peers.

    Outlook
    Merger with associate banks resulted in huge NPA stress and subsequently muted earnings in Q1FY18. However, the performance improved in Q2FY18 with slippages down considerably. Post complete integration, business growth will remain in focus. We believe capital raising via QIP, inflow of ~Rs 5000 crore from SBI Life stake sale and large capital infusion announced by the government, would be sufficient to meet provisions, growth requirements ahead. Capital adequacy ratio (CAR) is at 13.9% in Q2FY18 with Tier 1 capital at 10.9% Return ratios are expected to take longer to improve due to lower profits in merged entity. However, long term structural value of the bank remains intact. We revise our target price higher to Rs 390/share, valuing the merged bank at 1.8x FY19E ABV (Rs 168/share) and subsidiaries at Rs 79/share. Strategic stake in non-core investments like NSE (5.19%), BSE (4.75%), NSDL, ARCIL, UTI AMC, etc, may add further value, not factored in by us. We reiterate BUY.
    For all recommendations report, click here

    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Broker Research
    first published: Nov 28, 2017 05:22 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347